Non-arteritic Anterior Ischaemic Optic Neuropathy is Nearly Systematically Associated with Obstructive Sleep Apnoea

Overview

Journal Br J Ophthalmol

Specialty Ophthalmology

Date 2006 Mar 25

PMID 16556620

Citations 53

Authors

K Palombi

E Renard

P Levy

C Chiquet

Ch Deschaux

J P Romanet

J L Pepin

Affiliations

Soon will be listed here.

Abstract

Aim: To evaluate newly diagnosed non-arteritic anterior ischaemic optic neuropathy (NAION) patients for the existence of an associated sleep apnoea syndrome.

Methods: Newly identified NAION patient underwent polysomnography. The prevalence of sleep apnoea in NAION patients was compared to the prevalence previously found in the general population. Hypertension, diabetes, hyperlipidaemia, and atheromatous lesions of carotid vessels as classic risk factors associated with NAION were also identified.

Results: 27 consecutive newly diagnosed NAION patients (18 men and nine women, mean age 65 (SD 8) years, body mass index 27.2 (3.8) kg/m2) were included in the study. 24 of these 27 NAION patients (89%) exhibited a sleep apnoea syndrome (respiratory disturbance index: 37.2/h (SD 18.3/h). Risk ratio for a NAION patient to have sleep apnoea was 4.9 compared to the general population (p < 0.001). Sleep apnoea was 1.5-2-fold more frequent than the rate of the other identified risk factors typically associated with NAION (hypertension, diabetes).

Conclusions: Sleep apnoea is the most frequent disorder associated with NAION and should be screened in this population. At least a questionnaire related to obstructive sleep apnoea symptoms and assessment of sleepiness should be systematically proposed to patients with NAION.

Citing Articles

Obesity, body fat distribution and eye diseases.

Bosello F, Vanzo A, Zaffalon C, Polinelli L, Saggin F, Bonacci E Eat Weight Disord. 2024; 29(1):33.

PMID: 38710948 PMC: 11074037. DOI: 10.1007/s40519-024-01662-8.

[Nonarteritic anterior ischemic optic neuropathy (nAION)].

Beyer T, van Oterendorp C Ophthalmologie. 2023; 120(11):1159-1169.

PMID: 37851117 DOI: 10.1007/s00347-023-01938-x.

Ocular manifestations of obstructive sleep apnea: a systematic review and meta-analysis.

Bulloch G, Seth I, Zhu Z, Sukumar S, McNab A Graefes Arch Clin Exp Ophthalmol. 2023; 262(1):19-32.

PMID: 37227479 PMC: 10806133. DOI: 10.1007/s00417-023-06103-3.

Treatment of nonarteritic anterior ischemic optic neuropathy with an endothelin antagonist: ENDOTHELION (ENDOTHELin antagonist receptor in Ischemic Optic Neuropathy)-a multicentre randomised controlled trial protocol.

Chiquet C, Vignal C, Gohier P, Heron E, Thuret G, Rougier M Trials. 2022; 23(1):916.

PMID: 36309759 PMC: 9617347. DOI: 10.1186/s13063-022-06786-9.

Analysis of Systemic Risk Factors and Post-Insult Visual Development in a Danish Cohort of Patients with Nonarteritic Anterior Ischemic Optic Neuropathy.

Citirak G, Malmqvist L, Hamann S Clin Ophthalmol. 2022; 16:3415-3424.

PMID: 36249446 PMC: 9560866. DOI: 10.2147/OPTH.S384740.

References

Lavie L . Obstructive sleep apnoea syndrome--an oxidative stress disorder. Sleep Med Rev. 2003; 7(1):35-51. DOI: 10.1053/smrv.2002.0261. View

Suzuki T, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Yamauchi M . Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep. 2004; 27(1):129-33. DOI: 10.1093/sleep/27.1.129. View

Parish J, Somers V . Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc. 2004; 79(8):1036-46. DOI: 10.4065/79.8.1036. View

Young T, Shahar E, Nieto F, Redline S, Newman A, Gottlieb D . Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med. 2002; 162(8):893-900. DOI: 10.1001/archinte.162.8.893. View

Bengtsson B . The variation and covariation of cup and disc diameters. Acta Ophthalmol (Copenh). 1976; 54(6):804-18. DOI: 10.1111/j.1755-3768.1976.tb01801.x. View

Robinson G, Pepperell J, Segal H, Davies R, Stradling J . Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax. 2004; 59(9):777-82. PMC: 1747125. DOI: 10.1136/thx.2003.018739. View

Hayreh S, Podhajsky P, Zimmerman B . Ipsilateral recurrence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 2001; 132(5):734-42. DOI: 10.1016/s0002-9394(01)01192-8. View

. EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep. 1992; 15(2):173-84. View

Beck R, Hayreh S, Podhajsky P, Tan E, Moke P . Aspirin therapy in nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997; 123(2):212-7. DOI: 10.1016/s0002-9394(14)71038-4. View

10.

Repka M, Savino P, Schatz N, Sergott R . Clinical profile and long-term implications of anterior ischemic optic neuropathy. Am J Ophthalmol. 1983; 96(4):478-83. DOI: 10.1016/s0002-9394(14)77911-5. View

11.

Baguet J, Hammer L, Levy P, Pierre H, Rossini E, Mouret S . Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens. 2005; 23(3):521-7. DOI: 10.1097/01.hjh.0000160207.58781.4e. View

12.

Johnson L, Arnold A . Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol. 1994; 14(1):38-44. View

13.

Argod J, Pepin J, Levy P . Differentiating obstructive and central sleep respiratory events through pulse transit time. Am J Respir Crit Care Med. 1998; 158(6):1778-83. DOI: 10.1164/ajrccm.158.6.9804157. View

14.

Punjabi N, Ahmed M, Polotsky V, Beamer B, ODonnell C . Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol. 2003; 136(2-3):167-78. DOI: 10.1016/s1569-9048(03)00079-x. View

15.

PHILLIPS B, Narkiewicz K, Pesek C, HAYNES W, Dyken M, Somers V . Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999; 17(1):61-6. DOI: 10.1097/00004872-199917010-00010. View

16.

. Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996; 114(11):1366-74. DOI: 10.1001/archopht.1996.01100140566007. View

17.

Johnson L, Guy M, Krohel G, Madsen R . Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy. Ophthalmology. 2000; 107(3):521-6. DOI: 10.1016/s0161-6420(99)00133-5. View

18.

Newman N, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D . The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002; 134(3):317-28. DOI: 10.1016/s0002-9394(02)01639-2. View

19.

Arnold A . Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003; 23(2):157-63. DOI: 10.1097/00041327-200306000-00012. View

20.

Lavie L, Kraiczi H, Hefetz A, Ghandour H, Perelman A, Hedner J . Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med. 2002; 165(12):1624-8. DOI: 10.1164/rccm.20110-040OC. View